Form D · Biotechnology
C4 Imaging, LLC
Bellaire, TX · CIK 0001481933
Offering snapshot reported Jul 16, 2024 · SEC filing
- Reported sold
- $1.5M Offering amount: $1.5M
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 15, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,031,272 → $1,500,000
- Reported investors45 → 43
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 16, 2024 | Amendment | $1,500,000 | $468,728vs Mar 1, 2024 | 43 | SEC filing |
| Mar 1, 2024 | Initial | $1,031,272 | No comparison | 45 | SEC filing |
| Jun 18, 2018 | Initial | $1,200,000 | No comparison | 45 | SEC filing |
| Oct 14, 2016 | Initial | $1,100,000 | No comparison | 51 | SEC filing |
| Aug 7, 2013 | Amendment | $1,550,000 | $345,000vs Feb 14, 2013 | 30 | SEC filing |
| Feb 14, 2013 | Initial | $1,205,000 | No comparison | 29 | SEC filing |
| Aug 12, 2010 | Amendment | $2,000,000 | $550,000vs Feb 8, 2010 | 35 | SEC filing |
| Feb 8, 2010 | Initial | $1,450,000 | No comparison | 29 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506519
Amending to add the State of Kansas and to update amount sold.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| NA | None |
Source: Form D, filed Jul 16, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Bright | Executive |
| Steven J. Frank | Executive |
| Harry Maziar | Director |
| Jeff Seavey | Director |
| Steven Sheldon | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6575 West Loop South, Suite 500
Bellaire, TX, 77401
Bellaire, TX, 77401